From March 20th to 21st, the curtains rose on the 11th Annual Biologics Manufacturing Asia 2024 in the vibrant city of Singapore.

Gathering under one roof were industry experts and corporate trailblazers from around the globe, united in their quest to unravel the latest trends and future trajectories of the global biopharmaceutical landscape.

As the vanguard in the realm of three-dimensional cell manufacturing, CytoNiche captivated attendees with a dazzling array of showcases at this prestigious event.

Innovation Unleashed: From Core Products to Technologies

Witness the unveiling of our powerhouse trio: 3D TableTrix® & RecomTrix® microcarriers, 3D FloTrix® serum-free mesenchymal stem cell culture medium, and the revolutionary 3D FloTrix® vivaSPIN bioreactor. But that's not all—experience a groundbreaking simulation of the entire process path for "hundred billion scale" cell preparation, brought to life through an immersive sandbox model.

Breakthroughs Explored: Where Science Meets Application

Dr. Yan Xiaojun, CytoNiche's visionary co-founder & CTO, unveiled the game-changing potential of 3D TableTrix® Microcarriers in commercialized cell and gene therapy products. Dive deep into the technological marvels powering large-scale production preparation, automated processes, and the latest clinical applications—all made possible through the innovative use of 3D microcarriers.

Partnerships Forged: Connecting Globally, Succeeding Together

From renowned biopharmaceutical giants to cutting-edge research institutions, international partners flocked to the CytoNiche booth, eager to explore our diverse product portfolio and collaborative solutions. Through engaging introductions and fruitful discussions, numerous clients have already expressed keen interest in trial applications. With promising partnerships on the horizon, we're poised to amplify our impact on a global scale.

Vision

Igniting a New Era

in Industrial Cell Development

Singapore, as the bustling hub of biopharmaceutical innovation in the Asia-Pacific region, provides the perfect backdrop for CytoNiche's international debut. Our presence here marks a pivotal milestone in our journey towards global expansion—a journey fueled by a passion for collaboration, innovation, and transformative change.

Join us as we embark on this thrilling adventure, forging connections, sparking innovation, and shaping the future of biopharmaceuticals—one breakthrough at a time. CytoNiche: Lighting the Way to a Brighter Tomorrow.

[About CytoNiche]

CytoNiche was established in 2018, led by Professor Yanan Du's research team from the School of Medicine at Tsinghua University, with Tsinghua University as a shareholder. The core technology originated from the transformation of scientific achievements at Tsinghua University and was recognized as a leading technology in "Science and Technology Innovation in China" by the China Association for Science and Technology. As a national-level high-tech enterprise, a national-level specialized and new technology "Little Giant" enterprise, a potential unicorn enterprise, it has also received key research and development special support from the Ministry of Science and Technology.

As an expert in high-quality three-dimensional cell manufacturing, CytoNiche provides a one-stop customized solution for cell scale-up based on 3D microcarriers. The company has built an original 3D cell smart manufacturing platform, achieving large-scale, automated, intelligent, and closed-cell drug and derivative production preparation. This helps global customers establish the most advanced cell drug production lines. After pioneering the production process pipeline for "billion-level" stem cells, the company is accelerating towards "hundred billion-level," dedicating efforts to empower the cell and gene therapy industry with 3D cell scale-up smart manufacturing technology to benefit more patients.